Breathing machines assist patients suffering from chronic respiratory diseases, or those who are unable to breathe by themselves after anesthesia. Breathing machines are used during surgeries that require general anesthesia, as the medicines used to induce anesthesia can disrupt normal breathing. The machine is required after the surgery, as the patient may not be able to breathe immediately after the procedure. The type of breathing machine that is used varies according to the problem.
Ventilators are mainly used in emergency medicine, home care, intensive care medicine, and in anesthesia as a component of an anesthesia machine. The oxygen concentrator delivers pure oxygen through a mask or nasal cannula. It may be used in hyperbaric chambers and oxygen therapy. A C-PAP (continuous positive airway pressure) breathing machine blows air into the nose through a mask, which keeps the airway open and helps in the absorption of oxygen.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/2032
Nebulizers are generally used for the treatment of a range of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma. Medications are inhaled straight into the lungs for effective treatment. These machines help people suffering from asthma by delivering liquid medication through a mist, which is inhaled into the lungs through the machine. These devices are majorly used in home care settings.
Breathing Machines Market Dynamics
Increasing number of respiratory disorders such as asthma and COPD, and the rising number of surgeries are expected to drive growth of the global breathing machines market. According to the National Institute of Health’s data of 2014, asthma affects over 24 million people in the U.S. including over 6 million children. Breathing problems can also occur due to serious conditions such as pneumonia, tuberculosis, lung cancer, and other lung diseases. According to the World Health Organization’s (WHO) estimates, by 2030, the four major potentially fatal respiratory diseases including COPD, pneumonia, lung cancer, and tuberculosis will account for around one in five deaths worldwide.
Millions of people in the U.S. suffer from breathing problems such as chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. COPD is a progressive life-threatening lung disease that causes breathlessness and predisposition to exacerbations and serious illness. In 2016, the Global Burden of Disease study reported the prevalence of around 251 million cases of COPD worldwide. According to the same source, a total of 3.17 million deaths occurred due to COPD in 2015, which account for 5% of all deaths globally. COPD prevalence is expected to increase in the near future due to higher adoption of smoking habits, and the growing geriatric population in many economies worldwide.
However, few drawbacks of breathing machines include throat discomfort, damage to vocal cords, and sleeping discomfort. Some complications of using a breathing machine may include lung damage, collapsed lung, pneumonia or infection. Moreover, constant medical care is required when a breathing machine is used. These factors are expected to hinder growth of the market.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2032
Breathing Machines Market Regional Insights
On the basis of region, the global breathing machines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global breathing machines market in terms of revenue share owing to increasing number of patients receiving treatment for respiratory diseases. According to COPD International, in 2016, around 12 million people in the U.S. were suffering from COPD and an estimated 12 million more were undiagnosed. According to the Centers for Disease Control and Prevention’s (CDC) report, COPD is the fourth leading cause of death in the U.S.
Asia Pacific breathing machines market is expected to exhibit the highest CAGR owing to the increasing number of surgeries and the growing respiratory disease burden in the region. For instance, according to the WHO’s 2017 report, over 90% of COPD deaths occur in low- and middle-income economies. The primary cause of COPD is exposure to tobacco smoke. Other risk factors include exposure to indoor and outdoor air pollution and occupational fumes and dusts.
Breathing Machines Market: Competitive Landscape
Key players operating in the global breathing machines market include BD, Drager Medical, Fisher & Paykel, GE Healthcare, Invacare, Maque, Medtronic, OMRON, Philips Healthcare, Teijin Pharma Resmed, and Weinmann. Key players are focusing on improving breathing machines by developing energy-efficient power systems and product features such as lightweight maneuverability, long-lasting components, and patient-friendly design.
Breathing Machines Market: Taxonomy
On the basis of product type, the global breathing machines market is segmented into:
- PAP Devices
- Oxygen Concentrators
On the basis of end-user, the global breathing machines market is segmented into:
- Hospitals and clinics
- Home care settings
On the basis of region, the global breathing machines market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027